Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This Study is a Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Obese or Overweight Subjects Without Diabetes Mellitus.
Epistemonikos ID: 5fb628be2f2100484b89be5bf724f05f3958dcdf
First added on: Oct 04, 2025